Chapter 1. Research Framework
1.1 Research Objective
1.2 Product Overview
1.3 Market Segmentation
Chapter 2. Research Methodology
2.1 Qualitative Research
2.1.1 Primary & Secondary Sources
2.2 Quantitative Research
2.2.1 Primary & Secondary Sources
2.3 Breakdown of Primary Research Respondents, By Region
2.4 Assumption for the Study
2.5 Market Size Estimation
2.6. Data Triangulation
Chapter 3. Executive Summary: Asia Pacific Continuous Glucose Monitoring (CGM) Market
Chapter 4. Asia Pacific Continuous Glucose Monitoring (CGM) Market Overview
4.1. Industry Value Chain Analysis
4.1.1. Developer
4.1.2. Technology Integrator
4.1.3. Service Provider
4.1.4. End User
4.2. Industry Outlook
4.2.1. Prevalence of diabetes in Asia Pacific
4.2.2. Sales of Continuous Glucose Monitoring Devices in Asia Pacific
4.3. PESTLE Analysis
4.4. Porter's Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition
4.5. Market Dynamics and Trends
4.5.1. Growth Drivers
4.5.2. Restraints
4.5.3. Challenges
4.5.4. Key Trends
4.6. Covid-19 Impact Assessment on Market Growth Trend
4.7. Market Growth and Outlook
4.7.2. Price Trend Analysis, By Product
4.8. Competition Dashboard
4.8.1. Market Concentration Rate
4.8.2. Company Market Share Analysis (Value %), 2020
4.8.3. Competitor Mapping
Chapter 5. Continuous Glucose Monitoring (CGM) Market Analysis, By Application
5.1. Key Insights
5.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
5.2.1. Sensors
5.2.2. Transmitters & Receivers
5.2.3. Integrated Insulin Pumps
5.2.4. Others
Chapter 6. Continuous Glucose Monitoring (CGM) Market Analysis, By Demographics
6.1. Key Insights
6.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
6.2.1. Child Population (<14 years)
6.2.2. Adult Population (>14 years)
Chapter 7. Continuous Glucose Monitoring (CGM) Market Analysis, By End user
7.1. Key Insights
7.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
7.2.1. Diagnostics/Clinics
7.2.2. ICUs
7.2.3. Home Healthcare
Chapter 8. Continuous Glucose Monitoring (CGM) Market Analysis, By Region
8.1. Key Insights
8.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.4. South Korea
8.2.5. Australia & New Zealand
8.2.6. Indonesia
8.2.7. ASEAN
8.2.7.1. Malaysia
8.2.7.2. Thailand
8.2.7.3. Philippines
8.2.7.4. Vietnam
8.2.7.5. Singapore
8.2.8. Rest of Asia Pacific
Chapter 9. China Continuous Glucose Monitoring (CGM) Market Analysis
9.1. Key Insights
9.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
9.2.1. By Component
9.2.2. By Demographics
9.2.3. By End User
Chapter 10. India Continuous Glucose Monitoring (CGM) Market Analysis
10.1. Key Insights
10.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
10.2.1. By Component
10.2.2. By Demographics
10.2.3. By End User
Chapter 11. Japan Continuous Glucose Monitoring (CGM) Market Analysis
11.1. Key Insights
11.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
11.2.1. By Component
11.2.2. By Demographics
11.2.3. By End User
Chapter 12. South Korea Continuous Glucose Monitoring (CGM) Market Analysis
12.1. Key Insights
12.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
12.2.1. By Component
12.2.2. By Demographics
12.2.3. By End User
Chapter 13. Australia & New Zealand Continuous Glucose Monitoring (CGM) Market Analysis
13.1. Key Insights
13.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
13.2.1. By Component
13.2.2. By Demographics
13.2.3. By End User
Chapter 14. ASEAN Continuous Glucose Monitoring (CGM) Market Analysis
14.1. Key Insights
14.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
14.2.1. By Component
14.2.2. By Demographics
14.2.3. By End User
14.2.4. By Country
Chapter 15. Indonesia Continuous Glucose Monitoring (CGM) Market Analysis
15.1. Key Insights
15.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
15.2.1. By Component
15.2.2. By Demographics
15.2.3. By End User
Chapter 16. Rest of Asia Pacific Continuous Glucose Monitoring (CGM) Market Analysis
16.1. Key Insights
16.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
16.2.1. By Component
16.2.2. By Demographics
16.2.3. By End User
Chapter 17. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)
17.1. Abbott Laboratories
17.2. DexCom, Inc.
17.3. A. Menarini Diagnostics
17.4. Echo Therapeutics, Inc.
17.5. GlySens Incorporated
17.6. Johnson & Johnson
17.7. Medtronic plc
17.8. Senseonics Holdings, Inc.
17.9. F. Hoffmann-La Roche Ltd.
17.10. Other Prominent Players